In vitro, TERT mutated meningioma cells show decreased TERT activity in response to YK-4-279, a small molecule inhibitor of ETS transcription factor, suggesting a novel potential strategy for targeting these aggressive tumors. This evidence concerns the gene TERT and meningioma.